Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/recent-advances-and-future-challenges-in-the-treatment-of-upper-A6pmMqJv9X
References (27)
-
S. Sakuramoto, M. Sasako, Toshiharu Yamaguchi, T. Kinoshitá, M. Fujii, A. Nashimoto, H. Furukawa, T. Nakajima, Y. Ohashi, H. Imamura, M. Higashino, Y. Yamamura, A. Kurita, K. Arai (2007)
Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.The New England journal of medicine, 357 18
-
P. Thuss-Patience, A. Kretzschmar, D. Bichev, T. Deist, A. Hinke, K. Breithaupt, Y. Doğan, B. Gebauer, G. Schumacher, P. Reichardt (2011)
Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer--a randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).European journal of cancer, 47 15
-
Jeeyun Lee, D. Lim, Sung Kim, S. Park, Joon-Oh Park, Y. Park, Ho Lim, M. Choi, T. Sohn, J. Noh, J. Bae, Y. Ahn, I. Sohn, Sin-Ho Jung, C. Park, Kyoung-Mee Kim, W. Kang (2012)
Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 30 3
-
Edith Braun, Alejandro Fidalgo (2007)
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal CancerYearbook of Gastroenterology, 2007
-
X. Paoletti, K. Oba, T. Burzykowski, S. Michiels, Y. Ohashi, J. Pignon, P. Rougier, J. Sakamoto, D. Sargent, M. Sasako, E. Cutsem, M. Buyse (2010)
Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis.JAMA, 303 17
-
Julie Park, Jeffrey Scott, C. Stewart, W. London, A. Naranjo, V. Santana, P. Shaw, S. Cohn, K. Matthay (2011)
Pilot induction regimen incorporating pharmacokinetically guided topotecan for treatment of newly diagnosed high-risk neuroblastoma: a Children's Oncology Group study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 33
-
A Ohtsu, MA Shah, E Van Cutsem (2011)
Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III studyJ Clin Oncol., 29
-
S. Park, Do Lim, Kyung-Ah Park, Suyeon Lee, S. Oh, H. Kwon, J. Kang, I. Hwang, Junnam Lee, Joon-Tae Park, Yulri Park, H. Lim, Wonyoung Kang (2011)
A multicenter, randomized phase III trial comparing second-line chemotherapy (SLC) plus best supportive care (BSC) with BSC alone for pretreated advanced gastric cancer (AGC).Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 15_suppl
-
Y. Bang, Young-Woo Kim, Han-Kwang Yang, H. Chung, Young-Kyu Park, K. Lee, Keunsung Lee, Yong Kim, S. Noh, J. Cho, Y. Mok, Yeul-Hong Kim, J. Ji, T. Yeh, P. Button, F. Sirzén, S. Noh (2012)
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trialThe Lancet, 379
-
SH Park, DH Lim, S Lee (2011)
A multicenter, randomized phase III trial comparing second-line chemotherapy (SLC) plus best supportive care (BSC) with best supportive care alone for pretreated advanced gastric cancer (AGC)J Clin Oncol., 29
-
T. Andus, M. Anthuber, J. Arends, D. Arnold, D. Aust, P. Baier, G. Baretton, J. Bernhardt, H. Boeing, E. Böhle, C. Bokemeyer, J. Bornschein, W. Budach, E. Burmester, K. Caca, W. Diemer, C. Dietrich, M. Ebert, A. Eickhoff, C. Ell, J. Fahlke, H. Feußner, W. Fischbach, W. Fleig, M. Flentje, H. Gabbert, P. Galle, M. Geissler, I. Gockel, U. Graeven, L. Grenacher, S. Groß, J. Hartmann, V. Heinemann, B. Herbst, T. Herrmann, S. Höcht, R. Hofheinz, H. Höfler, T. Höhler, A. Hölscher, M. Horneber, J. Hübner, J. Izbicki, R. Jakobs, C. Jenssen, S. Kanzler, M. Keller, R. Kiesslich, G. Klautke, J. Körber, B. Krause, C. Kuhn, F. Kullmann, H. Lang, Florian Lordick, K. Ludwig, M. Lutz, R. Mahlberg, P. Malfertheiner, S. Merkel, H. Messmann, S. Mönig, P. Piso, S. Pistorius, R. Porschen, T. Rabenstein, P. Reichardt, K. Ridwelski, I. Roetzer, P. Rohr, W. Schepp, P. Schlag, R. Schmid, H. Schmidberger, G. Schuch, C. Schuhmacher, K. Schütte, W. Schwenk, M. Selgrad, A. Sendler, J. Seraphin, T. Seufferlein, Michael Stahl, H. Stein, C. Stoll, M. Stuschke, A. Tannapfel, R. Tholen, P. Thuss-Patience, K. Treml, U. Vanhoefer, M. Vieth, H. Vogelsang, D. Wagner, U. Wedding, A. Weimann, H. Wilke, C. Wittekind, M. Moehler (2011)
S3-Leitlinie "Magenkarzinom "- Diagnostik und Therapie der Adenokarzinome des Magens und ösophagogastralen Übergangs (AWMF-Regist.-Nr. 032-009-OL) German S3-Guideline "Diagnosis and Treatment of Esophagogastric Cancer" -
J. Valle, H. Wasan, D. Palmer, D. Cunningham, A. Anthoney, A. Maraveyas, S. Madhusudan, T. Iveson, S. Hughes, S. Pereira, M. Roughton, J. Bridgewater (2010)
Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.The New England journal of medicine, 362 14
-
J. Neoptolemos, M. Moore, T. Cox, J. Valle, D. Palmer, A. Mcdonald, R. Carter, N. Tebbutt, C. Dervenis, D. Smith, B. Glimelius, F. Coxon, F. Lacaine, M. Middleton, P. Ghaneh, C. Bassi, C. Halloran, A. Oláh, C. Rawcliffe, M. Büchler (2011)
Ampullary cancer ESPAC-3 (v2) trial: A multicenter, international, open-label, randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with adenocarcinoma of the ampulla of vater.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 15_suppl
-
D. Hoff, R. Ramanathan, M. Borad, D. Laheru, L. Smith, T. Wood, R. Korn, N. Desai, V. Trieu, J. Iglesias, Hui Zhang, P. Soon-Shiong, T. Shi, N. Rajeshkumar, A. Maitra, M. Hidalgo (2011)
Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 34
-
I. Songun, H. Putter, E. Kranenbarg, M. Sasako, C. Velde (2010)
Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.The Lancet. Oncology, 11 5
-
M. Ychou, V. Boige, J. Pignon, T. Conroy, O. Bouché, G. Lebreton, M. Ducourtieux, L. Bedenne, J. Fabre, B. Saint‐Aubert, J. Genève, P. Lasser, P. Rougier (2011)
Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 13
-
T. Conroy, F. Desseigne, M. Ychou, O. Bouché, R. Guimbaud, Y. Bécouarn, A. Adenis, J. Raoul, S. Gourgou-Bourgade, C. Fouchardière, J. Bennouna, J. Bachet, F. Khemissa-Akouz, D. Péré-Vergé, C. Delbaldo, E. Assenat, B. Chauffert, P. Michel, C. Montoto-Grillot, M. Ducreux (2011)
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.The New England journal of medicine, 364 19
-
T. Bekaii-Saab, M. Phelps, Xiaobai Li, M. Saji, L. Goff, J. Kauh, B. O'Neil, Stephanie Balsom, C. Balint, R. Liersemann, V. Vasko, M. Bloomston, W. Marsh, L. Doyle, G. Ellison, M. Grever, M. Ringel, M. Villalona-Calero (2011)
Multi-institutional phase II study of selumetinib in patients with metastatic biliary cancers.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 17
-
J. Yi, S. Thongprasert, Jeeyun Lee, D. Doval, S. Park, Joon-Oh Park, Y. Park, W. Kang, Ho Lim (2012)
A phase II study of sunitinib as a second-line treatment in advanced biliary tract carcinoma: a multicentre, multinational study.European journal of cancer, 48 2
-
E. Assaf, M. Verlinde-Carvalho, C. Delbaldo, J. Grenier, Zineb Sellam, D. Pouessel, L. Bouaita, I. Baumgaertner, I. Sobhani, C. Tayar, M. Paul, S. Culine (2011)
5-Fluorouracil/Leucovorin Combined with Irinotecan and Oxaliplatin (FOLFIRINOX) as Second-Line Chemotherapy in Patients with Metastatic Pancreatic AdenocarcinomaOncology, 80
-
Y. Bang, E. Cutsem, A. Feyereislova, H. Chung, L. Shen, A. Sawaki, F. Lordick, A. Ohtsu, Y. Omuro, T. Satoh, G. Aprile, E. Kulikov, Julie Hill, M. Lehle, J. Rüschoff, Yoon-Koo Kang (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialThe Lancet, 376
-
C. Schuhmacher, S. Gretschel, F. Lordick, P. Reichardt, W. Hohenberger, C. Eisenberger, C. Haag, M. Mauer, B. Hasan, J. Welch, K. Ott, A. Hoelscher, P. Schneider, W. Bechstein, H. Wilke, M. Lutz, B. Nordlinger, E. Cutsem, J. Siewert, P. Schlag (2010)
Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28 35
-
A. Wagner, D. Arnold, A. Grothey, J. Haerting, S. Unverzagt (2009)
Anti-angiogenic therapies for metastatic colorectal cancer.The Cochrane database of systematic reviews, 3
-
Jeeyun Lee, S. Park, H. Chang, Jun Kim, H. Choi, Myung Lee, J. Jang, H. Jeung, J. Kang, Hyun Lee, D. Shin, H. Kang, Jong-Mu Sun, Joon-Oh Park, Y. Park, W. Kang, Ho Lim (2012)
Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study.The Lancet. Oncology, 13 2
-
D. Cunningham, W. Allum, S. Stenning, J. Thompson, C. Velde, M. Nicolson, J. Scarffe, F. Lofts, S. Falk, T. Iveson, David Smith, R. Langley, M. Verma, S. Weeden, Y. Chua, MAGIC Participants (2006)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.The New England journal of medicine, 355 1
-
E. Chiorean (2012)
Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III StudyYearbook of Oncology, 2012
-
M Moehler, SE Al-Batran, T Andus, M Anthuber, J Arends, D Arnold (2011)
German S3-guideline “Diagnosis and treatment of esophagogastric cancer”.Z Gastroenterol., 49
- Publisher
- Springer Journals
- Copyright
- Copyright © 2012 by Springer-Verlag Wien
- Subject
- Medicine & Public Health; Medicine/Public Health, general; Oncology
- ISSN
- 1865-5041
- eISSN
- 1865-5076
- DOI
- 10.1007/s12254-012-0001-8
- Publisher site
- See Article on Publisher Site
Abstract
This update includes articles on upper GI-cancers published in 2011 and in early 2012, which we consider particularly interesting for medical oncologists. In addition, abstracts from the 2011 ASCO meeting are also considered We reviewed the important literature in the field of GI-oncology and selected articles, which addressed key topics related to the treatment of esophageal and gastric cancer, and of cancers of the pancreas, the ampulla of Vater and the biliary tract, respectively. As the format of a short review is limited, we have focused on articles which are considered relevant for routine care.
Journal
memo - Magazine of European Medical Oncology – Springer Journals
Published: Jun 9, 2012